B. Riley Financial Varied
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bio-Rad Laboratories, Inc. Class A Common Stock (NY:BIO)

332.78 -1.93 (-0.58%)
Streaming Delayed Price Updated: 3:35 PM EDT, Aug 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Bio-Rad Laboratories, Inc. Class A Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Bio-Rad vs. Charles River Labs: Which Medical Research Stock Is a Better Buy in 2026? ↗
Bio-Rad posts robust margins and liquidity, while Charles River leads in global drug discovery services. Explore how their fundamentals stack up for investors. 
Via The Motley Fool
News headline image
Why Elliott Sees Hidden Billions Inside Bio-Rad Laboratories ↗
Elliott Management builds a stake in Bio-Rad (NYSE: BIO) to push for better performance, but family voting control could pose a hurdle. 
Via Benzinga
News headline image
Bio-Rad (BIO) Q2 2025 Earnings Call Transcript ↗
Bio-Rad (BIO) Q2 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
Bio-Rad Q1 2026 Revenue Misses Estimates, Outlook Cut as NYSE:BIO Faces Cautious Trading ↗
Via Chartmill
Bio-Rad Laboratories (NYSE:BIO) Stock Plummets 12% After Q4 Earnings Miss and Weak 2026 Outlook ↗
Via Chartmill
Topics Earnings
News headline image
Earnings Scheduled For October 29, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For July 31, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 1, 2025 ↗
 
Via Benzinga
News headline image
A Preview Of Bio-Rad Laboratories's Earnings ↗
 
Via Benzinga
News headline image
Bio-Rad (BIO) Q1 2026 Earnings Transcript ↗
Bio-Rad (BIO) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics World Trade
News headline image
Bio-Rad (BIO) Q4 2025 Earnings Call Transcript ↗
Bio-Rad (BIO) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Why a Fund Trimmed a $41 Million CompoSecure Stake Amid a 47% Stock Run ↗
Amid a monster year and, more recently, a transformative deal announcement, this move raises a sharper question about how much upside is really left at today’s valuation. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Earnings Scheduled For February 13, 2025 ↗
 
Via Benzinga
News headline image
The Analyst Verdict: Bio-Rad Laboratories In The Eyes Of 4 Experts ↗
 
Via Benzinga
News headline image
Expert Ratings For Bio-Rad Laboratories ↗
 
Via Benzinga
News headline image
Triple-Witch Says, “Remember Me?” ↗
Via Talk Markets
News headline image
Why a Fund Cut $4 Million of Payoneer Stock Despite Record Revenues ↗
Payoneer just posted record revenue and raised guidance, yet one fund trimmed its stake. The disconnect is where the real story is. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why Bio-Rad Laboratories Stock Slipped by More Than 3% on Thursday ↗
The company doesn't seem like it will generate pops in key fundamentals anytime soon. 
Via The Motley Fool
Topics Supply Chain
News headline image
Thermo Fisher Scientific Soars on Strategic Wins, Market Optimism
Thermo Fisher Scientific Inc. (NYSE: TMO) experienced a robust surge in its stock value today, October 1, 2025, climbing an impressive 9.79% as market optimism swelled around a series of recent... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
News headline image
Bio-Rad (BIO) Q2 EPS Jumps 51% ↗
Via The Motley Fool
News headline image
Bio-Rad Laboratories Analysts Raise Their Forecasts After Better-Than-Expected Q2 Earnings ↗
 
Via Benzinga
News headline image
Monolithic Power Systems, Workiva, Interface, AppFolio And Other Big Stocks Moving Higher On Friday ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
These stocks are moving in today's after hours session ↗
Discover the top movers in Thursday's after-hours session and stay informed about the post-market dynamics. 
Via Chartmill
News headline image
5 Analysts Have This To Say About Bio-Rad Laboratories ↗
 
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Stocks Head For Weekly Gains, US Treasury Yields Fall Below 4.5%: What's Driving Markets Friday? ↗
Stocks are headed for weekly gains, with the Dow Jones dipping slightly and the S&P 500 and Nasdaq trading just above the flatline Friday. 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Palantir Stock Will Join the S&P 500 in September. History Says It Could Soar Afterward. ↗
History says Palantir stock could soar after its inclusion in the S&P 500. 
Via The Motley Fool
Topics Stocks
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
B. Riley Financial's diverse suite of services goes beyond traditional financial service offerings. By leveraging cross-platform expertise and assets, B. Riley Financial companies are uniquely positioned to provide full service, collaborative solutions to our clients at every stage of the business life cycle and in all market conditions.

B. Riley refers to B. Riley Financial, Inc. and/or one or more of its subsidiaries or affiliates. Click here for further details.